HIGHLIGHTS
SUMMARY
An abundance of Parkinson`s disease (PD) data spanning many different modalities (genetic, transcriptomic, proteomic, 1 epigenomic, clinical, and more) has been generated over the past few years. Bringing researchers together to share data, code, tools, and pipelines will help reproducibility and create lower entry points to generate the results needed to make the necessary progress in PD research. IPDGC and GP2 exist to drive forward research into the genetic basis of PD, and for both initiatives, training and collaboration are vital aspects of accelerating and diversifying research efforts. GP2 has recently partnered with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.